Variant ID | 29813 |
---|---|
Entrez Gene ID | 7791 |
Gene | ZYX (GeneCards) |
Location | hg19 7:143079777-143079777
hg38 7:143382684-143382684 |
Disease | Autism Spectrum Disorders (view all the variants in this disease) |
Method | NextSeq500 |
Mutation(HGVS format) | NC_000007.13:g.143079777 G>A (Genome Assembly: hg19) |
Exon or Intron | Exon |
---|---|
Position in protein | NA |
Amino acid changes in protein | NA > NA |
Position in cDNA | NA |
Changes in cDNA | NA > NA |
mRNA accession | NA |
mRNA length | NA |
Reference length | 159138663 |
MAF in gnomAD genome (version 2.0.1) | 0 |
---|---|
EIGEN score | 0.4228 |
CADD Raw score (version 1.3) | 4.451222 (Deleterious) |
FATHMM raw prediction score | 0.41815 (Tolerated) |
SIFT score | 0.001 (Deleterious) |
LRT score | 0.253 (Tolerated) |
MutationTaster score | 1 (Deleterious) |
MutatioinAssessor score | 2.43 (Deleterious) |
PROVEAN score | -1.23 (Tolerated) |
MetaSVM score | -0.545 (Tolerated) |
MetaLR score | 0.289 (Tolerated) |
MCAP score | 0.047 (Deleterious) |
FitCons score | 0.767 (Highly Significant p < 0.003 ) |
Genomic Evolutionary Rate Profiling (GERP) score | 2.66 |
PhyloP score based on multiple alignment of 100 vertebrates | 4.989 |
PhastCons score based on multiple alignment of 100 vertebrates | 1 |
SiPhy log transformed odds ratio on multiple alignment of 29 mammals | 10.588 |
Deleterious probability by iFish2 | 0.4064 (Neutral) |
Deleterious probability by DeFine | 0.9143 (Deleterious) |
Entrez Gene ID | 7791 (NCBI Gene) |
---|---|
Official Gene Symbol | ZYX (GeneCards) |
Number of variants in ZYX in this database | 1 (view all the variants) |
Full name | zyxin |
Band | 7q34 |
Other IDs | Vega: OTTHUMG00000023822 OMIM: 602002 HGNC: HGNC:13200 Ensembl: ENSG00000159840 |
Other names | ESP-2, HED-2 |
Summary | Focal adhesions are actin-rich structures that enable cells to adhere to the extracellular matrix and at which protein complexes involved in signal transduction assemble. Zyxin is a zinc-binding phosphoprotein that concentrates at focal adhesions and along the actin cytoskeleton. Zyxin has an N-terminal proline-rich domain and three LIM domains in its C-terminal half. The proline-rich domain may interact with SH3 domains of proteins involved in signal transduction pathways while the LIM domains are likely involved in protein-protein binding. Zyxin may function as a messenger in the signal transduction pathway that mediates adhesion-stimulated changes in gene expression and may modulate the cytoskeletal organization of actin bundles. Alternative splicing results in multiple transcript variants that encode the same isoform. [provided by RefSeq, Jul 2008] |
Individual ID | 28867142.52 (view all the variants in this individual) |
---|---|
Pubmed ID | 28867142 |
Whose mosaic mutation | Male Patient |
Origin of mosaic mutation in patients | de novo |
Phenotype | 3 |
Disease | Autism Spectrum Disorders (view all the variants in this disease) |
OMIM ID | 209850 |
Pubmed ID | 28867142 |
---|---|
Title | Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder |
Journal | American Journal of Human Genetics |
Publication date | 2017.08 |
Disease | Autism Spectrum Disorders |
Incidence | 0.01 |
Number of cases | cases of unknown sex: 247; |